EGF and cancer: The fact that COX2 c.-899G>C, EGF c.382A>G, and EGFR c.1562G>A polymorphisms were not directly associated with cancer risk is not surprising, considering that most of these polymorphic variants are low penetrance risk factors that have a minor influence in protein expression or function.